Davion Healthcare Plc Appoints Vienna Capital Partners to Support US$100 Million Acquisition Financing Strategy
Key Highlights
- ➤Davion appoints Vienna Capital to support US$100 million-plus 2027 acquisition financing strategy
- ➤Davion targets senior secured, non-convertible debt to minimize shareholder dilution
- ➤Proposed $13.5 million Healthcare Stat Homecare acquisition precedes broader acquisition program
- ➤US$100 million target is indicative; no binding lender commitments or credit facility secured
Expert Statements
Glenn Williams, Chief Executive Officer of Davion
“Our strategy is to build a substantial healthcare and related services group by combining our proprietary technologies with established, profitable businesses that bring revenues, earnings and operational capabilities.”
Glenn Williams, Chief Executive Officer of Davion
“The appointment of Vienna Capital is an important step in developing the financing arrangements to support that ambition.”
Glenn Williams, Chief Executive Officer of Davion
“Our initial US$100 million financing objective reflects the scale of the acquisition opportunities we intend to pursue during 2027, and our preference is to use institutional debt wherever commercially appropriate, allowing us to expand while limiting dilution for existing shareholders.”
Glenn Williams, Chief Executive Officer of Davion
“We look forward to working with Vienna Capital as we progress our acquisition program.”
Dr Vincent deFilippo, Chief Executive Officer of Vienna Capital Partners LLC
“Davion has an exciting opportunity to combine innovative healthcare technologies with established, profitable businesses to build a diversified healthcare group.”
Dr Vincent deFilippo, Chief Executive Officer of Vienna Capital Partners LLC
“We believe its acquisition strategy offers a compelling platform for long-term growth, and we are pleased to support the Company in evaluating institutional financing opportunities and developing the financial structures needed to pursue its ambitions.”
DUBLIN, Nov. 06, 2026 (GLOBE NEWSWIRE) -- Davion Healthcare Plc (NASDAQ: DAVI) (“Davion” or the “Company”), a developer of non-invasive health monitoring technologies, announces that it has entered into a non-exclusive financial advisory agreement with Vienna Capital Partners LLC (“Vienna Capital”), a New York-based financial services firm, to support its proposed US$100 million-plus acquisition financing strategy for 2027.
The appointment forms part of Davion’s strategy to build a diversified healthcare and related services group through the acquisition of established, profitable and cash-generative businesses, principally in the United States. It follows the Company’s recent announcement of its proposed $13.5 million acquisition of Healthcare Stat Homecare Inc., a profitable US home healthcare business.
Get started
Create a free account to read the full story.